View in EDS

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.

Saved in:
Bibliographic Details
Title: Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
Authors: Casulo C; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA. Electronic address: carla_casulo@urmc.rochester.edu., Larson MC; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Lunde JJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Habermann TM; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lossos IS; Department of Medicine, Comprehensive Sylvester Cancer Center, University of Miami, Miami, FL, USA., Wang Y; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Nastoupil LJ; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Strouse C; Department of Medicine, University of Iowa, Iowa City, IA, USA., Chihara D; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Martin P; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Cohen JB; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Kahl BS; Department of Medicine, Washington University in St Louis, St Louis, MO, USA., Burack WR; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA., Koff JL; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Mun Y; Genentech, South San Francisco, CA, USA., Masaquel A; Genentech, South San Francisco, CA, USA., Wu M; Genentech, South San Francisco, CA, USA., Wei MC; Genentech, South San Francisco, CA, USA., Shewade A; Genentech, South San Francisco, CA, USA., Li J; Genentech, South San Francisco, CA, USA., Cerhan J; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Flowers CR; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Link BK; Department of Medicine, University of Iowa, Iowa City, IA, USA., Maurer MJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Source: The Lancet. Haematology [Lancet Haematol] 2022 Apr; Vol. 9 (4), pp. e289-e300.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35358443
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Casulo+C%22">Casulo C</searchLink>; Department of Medicine, Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA. Electronic address: carla_casulo@urmc.rochester.edu.<br /><searchLink fieldCode="AU" term="%22Larson+MC%22">Larson MC</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lunde+JJ%22">Lunde JJ</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Habermann+TM%22">Habermann TM</searchLink>; Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lossos+IS%22">Lossos IS</searchLink>; Department of Medicine, Comprehensive Sylvester Cancer Center, University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Nastoupil+LJ%22">Nastoupil LJ</searchLink>; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Strouse+C%22">Strouse C</searchLink>; Department of Medicine, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Chihara+D%22">Chihara D</searchLink>; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Martin+P%22">Martin P</searchLink>; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+JB%22">Cohen JB</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Kahl+BS%22">Kahl BS</searchLink>; Department of Medicine, Washington University in St Louis, St Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Burack+WR%22">Burack WR</searchLink>; Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Koff+JL%22">Koff JL</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Mun+Y%22">Mun Y</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Masaquel+A%22">Masaquel A</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+M%22">Wu M</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wei+MC%22">Wei MC</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shewade+A%22">Shewade A</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cerhan+J%22">Cerhan J</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Flowers+CR%22">Flowers CR</searchLink>; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Link+BK%22">Link BK</searchLink>; Department of Medicine, University of Iowa, Iowa City, IA, USA.<br /><searchLink fieldCode="AU" term="%22Maurer+MJ%22">Maurer MJ</searchLink>; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101643584%22">The Lancet. Haematology</searchLink> [Lancet Haematol] 2022 Apr; Vol. 9 (4), pp. e289-e300.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101643584 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3026 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523026%22">23523026 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35358443
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2352-3026(22)00033-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e289
    Titles:
      – TitleFull: Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Casulo C
      – PersonEntity:
          Name:
            NameFull: Larson MC
      – PersonEntity:
          Name:
            NameFull: Lunde JJ
      – PersonEntity:
          Name:
            NameFull: Habermann TM
      – PersonEntity:
          Name:
            NameFull: Lossos IS
      – PersonEntity:
          Name:
            NameFull: Wang Y
      – PersonEntity:
          Name:
            NameFull: Nastoupil LJ
      – PersonEntity:
          Name:
            NameFull: Strouse C
      – PersonEntity:
          Name:
            NameFull: Chihara D
      – PersonEntity:
          Name:
            NameFull: Martin P
      – PersonEntity:
          Name:
            NameFull: Cohen JB
      – PersonEntity:
          Name:
            NameFull: Kahl BS
      – PersonEntity:
          Name:
            NameFull: Burack WR
      – PersonEntity:
          Name:
            NameFull: Koff JL
      – PersonEntity:
          Name:
            NameFull: Mun Y
      – PersonEntity:
          Name:
            NameFull: Masaquel A
      – PersonEntity:
          Name:
            NameFull: Wu M
      – PersonEntity:
          Name:
            NameFull: Wei MC
      – PersonEntity:
          Name:
            NameFull: Shewade A
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Cerhan J
      – PersonEntity:
          Name:
            NameFull: Flowers CR
      – PersonEntity:
          Name:
            NameFull: Link BK
      – PersonEntity:
          Name:
            NameFull: Maurer MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2022 Apr
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2352-3026
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: The Lancet. Haematology
              Type: main
ResultId 1